Clinical Trials Directory

Trials / Completed

CompletedNCT03314610

Effect of Need to Void on Parkinsonian Gait

Status
Completed
Phase
Study type
Observational
Enrollment
11 (actual)
Sponsor
Pierre and Marie Curie University · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the effect of the need to void on parkinsonian gait

Detailed description

Parkinsonian syndromes are common causes of gait disorders, associated with hypometria, bradykinesia or rigidity. If motor disorders are the most visible part, lower urinary tract dysfunction is one of the most prevalent dysautonomic disorder (27-80%), especially over active bladder syndrome (OAB). If it seems evident that gait and urinary disorders are linked, because of similar anatomic pathways and control processes, no studies have investigated their association in extrapyramidal patients. The aim of this study is to assess the effect of the need to void on the walking speed in this particular population. This prospective study inclues all parkinsonian syndromes who had a follow-up for OAB. They must have a security delay over five minutes, no severe cognitive, motor or psychiatric disorders. We invite them to drink until a need to void (or equivalent). Bladder filling is measured by bladder scan, then they performe gait tests in a specific place, with calm and no passage : Patient can use their habitual walking device. Speed walk asking is comfortable for the two test. Three ten-meter tests, one double-task ten-meter test, one timed-up-and-go test, one timed raise of the floor (GMT). We repeat the same tests after voiding or self-catheterization. Toilets are just next to the hall where they realize the tests. A clinical examination assesses urinary dysfunction (USP, IPSS), motor score (UPDRS-III, Hoehn and Yahr scale, daily equivalent of levodopa), history of falls and comorbidities.

Conditions

Interventions

TypeNameDescription
OTHERGait speedNo intervention, only propose water and wait for need to void

Timeline

Start date
2017-10-16
Primary completion
2017-12-28
Completion
2017-12-30
First posted
2017-10-19
Last updated
2019-09-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03314610. Inclusion in this directory is not an endorsement.